Cetirizine Hydrochloride Tablets 5 mg
Rising Pharma recalls Cetirizine HCl 5 mg tablets due to ranitidine cross-contamination.
Stop using the recalled tablets and return them to the place of purchase for a refund. Contact Rising Pharma Holdings for further instructions.
Why it was recalled
Rising Pharma Holdings is recalling Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottles, due to cross-contamination with ranitidine. Customer complaints reported discolored tablets and red dots, which were determined to be ranitidine.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Cetirizine Hydrochloride Tablets USP 5 mg, Pack 100’s HDPE containerBest-by: 10/2028NDC: 16571-401-10Distribution: Rising Pharma Holdings Inc.Manufacturer: Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.)
| Lot code |
|---|
| GY825029 |
| GY825030 |
| GY825031 |
| GY825032 |
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Contamination recalls
Other recent recalls from JB Chemicals and Pharmaceuticals Ltd
Editorial summary by Recall Canary · summary updated 2026-08-04 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification